Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 20, 2021

SELL
$5.28 - $9.64 $21,405 - $39,080
-4,054 Closed
0 $0
Q4 2020

Jan 29, 2021

BUY
$5.75 - $7.13 $23,310 - $28,905
4,054 New
4,054 $26,000
Q3 2020

Oct 15, 2020

SELL
$4.9 - $7.12 $71,883 - $104,450
-14,670 Closed
0 $0
Q2 2020

Jul 14, 2020

BUY
$6.43 - $9.86 $16,505 - $25,310
2,567 Added 21.21%
14,670 $107,000
Q1 2020

Apr 23, 2020

BUY
$6.36 - $10.05 $76,975 - $121,635
12,103 New
12,103 $84,000
Q4 2019

Feb 11, 2020

SELL
$8.49 - $12.81 $98,076 - $147,981
-11,552 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$5.58 - $14.47 $64,460 - $167,157
11,552 New
11,552 $129,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Fortem Financial Group, LLC Portfolio

Follow Fortem Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortem Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortem Financial Group, LLC with notifications on news.